These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1694165

  • 1. Biological activities of new anthracyclines containing fluorine, FAD104 and its metabolites.
    Kunimoto S, Komuro K, Nosaka C, Tsuchiya T, Fukatsu S, Takeuchi T.
    J Antibiot (Tokyo); 1990 May; 43(5):556-65. PubMed ID: 1694165
    [Abstract] [Full Text] [Related]

  • 2. Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
    Umezawa K, Takeuchi T, Komuro K, Nosaka C, Kunimoto S, Tsuchiya T, Takagi Y, Umezawa S, Umezawa H.
    Drugs Exp Clin Res; 1988 May; 14(7):429-34. PubMed ID: 3240703
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity and metabolism of a new anthracycline-containing fluorine (ME2303) in Lewis lung carcinoma-bearing mice.
    Iigo M, Hoshi A, Kadosawa H, Fujigaki M.
    Jpn J Cancer Res; 1991 Nov; 82(11):1317-21. PubMed ID: 1752788
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K, Takagi Y, Tsuchiya T.
    Carbohydr Res; 1999 Mar 31; 316(1-4):47-57. PubMed ID: 10420587
    [Abstract] [Full Text] [Related]

  • 5. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 6. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W, Neamati N, Perez-Soler R.
    J Antibiot (Tokyo); 1990 Jul 15; 43(7):838-46. PubMed ID: 2387778
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y, Kobayashi N, Chang MS, Lim GJ, Tsuchiya T.
    Carbohydr Res; 1998 Feb 15; 307(3-4):217-32. PubMed ID: 9675364
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K, Takagi Y, Tsuchiya T, Umezawa S, Umezawa H.
    Carbohydr Res; 1987 Nov 15; 169():69-81. PubMed ID: 3427590
    [Abstract] [Full Text] [Related]

  • 9. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y, Park H, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug 15; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract] [Full Text] [Related]

  • 10. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A, Ciesielska E, Szmigiero L, Robak T.
    Eur J Haematol; 2002 Jun 15; 68(6):370-5. PubMed ID: 12225395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Takagi Y, Kobayashi N, Tsuchiya T, Umezawa S, Takeuchi T, Komuro K, Nosaka C.
    J Antibiot (Tokyo); 1989 Aug 15; 42(8):1318-20. PubMed ID: 2759915
    [No Abstract] [Full Text] [Related]

  • 14. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M.
    Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497
    [Abstract] [Full Text] [Related]

  • 15. Sonodynamically-induced cell damage with fluorinated anthracycline derivative, FAD104.
    Yumita N, Umemura S, Kaneuchi M, Okano Y, Magario N, Ishizaki M, Shimizu K, Sano Y, Umemura K, Nishigaki R.
    Cancer Lett; 1998 Mar 13; 125(1-2):209-14. PubMed ID: 9566717
    [Abstract] [Full Text] [Related]

  • 16. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S, Singh SV, Samy TS, Krishan A.
    Biochem Pharmacol; 1990 Feb 15; 39(4):723-8. PubMed ID: 2306280
    [Abstract] [Full Text] [Related]

  • 17. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 15; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.